Two More Pharma Companies Launch On TrumpRx
The Pro DeSantis News homepage has 60 new headlines every 24 hours - click here to see it.
Abbvie and Genentech will now be selling medication on TrumpRx.
They will become the 10th and 11th companies to do so.
Two more drug-making giants will officially start selling popular commercial medications on the White House’s discounted pharmaceutical site as soon as Monday, CBS News exclusively learned.
American pharmaceutical companies Abbvie and Genentech become the 10th and 11th companies to provide their prescriptions at a reduced rate on the “TrumpRx” site.
Abbvie, which struck a deal with the Trump administration in January to cut the cost of certain medicines, will sell Humira, a popular medication used to treat rheumatoid arthritis, Crohn’s disease and ulcerative colitis, on the site at an 86% discount.
The prescription prices on the site, however, are only available to patients who are uninsured, or whose insurance doesn’t cover it, and who must pay the full list price out of pocket. Those with insurance coverage generally pay lower prices already.
Abbvie will sell the medication Humira at a 86% discount.
Gentech will sell Xofluza.
It will now cost $50 instead of $168.
Abbvie will sell its popular medication Humira, which is used to treat rheumatoid arthritis, Crohn’s disease and ulcerative colitis, on the site at an 86% discount, according to CBS News. Genentech will sell its flu-prevention drug Xofluza.
The Humira pen is now expected to cost uninsured Americans $950, down from as high as $6,900, and a prescription of Xofluza will cost $50 instead of $168, the outlet reported.
The new additions will bring the total up to 61 drugs that the website now offers at a discounted price. TrumpRx offered discounted prices for 40 of the most popular and expensive medications in the country, including Ozempic and Wegovy, which help treat diabetes, heart disease and obesity, at its launch.
